Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC

Authors: Imber, Brandon S., Sehgal, Ryka, Saganty, Rachel, Reiner, Anne S., Ilica, A. Turan, Miao, Emily, Li, Bob T., Riely, Gregory J., Yu, Helena A., Panageas, Katherine S., Young, Robert J., Pike, Luke R.G., Moss, Nelson S.

Source: In JTO Clinical and Research Reports December 2023 4(12)

Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis

Authors: Lin, Jenny, Sharaf, Ravi N., Saganty, Rachel, Ahsan, Danyal, Feit, Julia, Khoury, Andrea, Bergeron, Hannah, Chapman-Davis, Eloise, Cantillo, Evelyn, Holcomb, Kevin, Blank, Stephanie V., Liu, Ying, Thomas, Charlene, Christos, Paul J., Wright, Drew N., Lipkin, Steven, Offit, Kenneth, Frey, Melissa K.

Source: In Gynecologic Oncology August 2021 162(2):506-516

Disparities in genetic testing for women with ovarian cancer: a systematic review

Authors: Lin, Jenny, Feit, Julia, Khoury, Andrea, Saganty, Rachel, Wright, Drew, Thomas, Charlene, Christos, Paul, Sharaf, Ravi, Frey, Melissa

Source: In Gynecologic Oncology August 2021 162 Supplement 1:S135-S136

A systematic review and meta-analysis of genetic assessment for women with ovarian cancer: how can we do better?

Authors: Lin, Jenny, Saganty, Rachel, Feit, Julia, Khoury, Andrea, Zhou, Zhen Ni, Wright, Drew, Thomas, Charlene, Christos, Paul, Chapman-Davis, Eloise, Cantillo, Evelyn, Holcomb, Kevin, Sharaf, Ravi, Frey, Melissa

Source: In Gynecologic Oncology August 2021 162 Supplement 1:S79-S80